The shareholders in Ørsted and Novo Nordisk have much to be happy about today, as both companies have decided to issue large dividends following the declaration of record profits.
While Ørsted will split DKK 5.7 billion, Novo will distribute DKK 14.8 billion – not bad for shareholders who split DKK 7.5 billion in August last year.
Handy sales accounted for a large share
The energy giant Ørsted, which has almost completely weaned itself from gas (Dong Energy Days) to concentrate exclusively on renewable energy, has announced a record operating profit of DKK 32 billion for 2022 – a significant increase compared to the 7.8 billion that was notified in 2021.
It attributed the improvement to the partial sale of the offshore wind farm Hornsea 2, which brought in just over DKK 10 billion.
Diabetes and obesity treatments weigh in
Meanwhile, a profit after tax of 55.5 billion kroner on sales of 177 billion – a 26 percent increase compared to 2021 – has led Novo Nordisk to forecast growth of 13-19 percent for 2023.
Treatments for diabetes and obesity accounted for the lion’s share: up 29 percent to 156.4 billion, driven by a 35 percent jump in North American sales.
Source: The Nordic Page
